Here's a 2.7% dividend yield that has been growing by 10%-plus annually -- and it's undervalued, too.

Don't sleep on these medical device leaders.

Becton Dickinson (BDX) is back on investors’ radar after a reshuffle in Russell indices, with the stock added to the Russell ...

Shares of Becton Dickinson & Co. BDX shed 1.10% to $158.17 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.01% to 7,457.69 ...

6 analysts have shared their evaluations of Becton Dickinson (NYSE:BDX) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick ...

Throughout the last three months, 5 analysts have evaluated Becton Dickinson (NYSE:BDX), offering a diverse set of opinions from bullish to bearish. The table below provides a concise overview of ...

Becton Dickinson stock has fallen 22.8% year to date, yet the valuation checks and an intrinsic value estimate based on a ...

On Thursday, BD (Becton, Dickinson and Company) (NYSE:BDX) reported second-quarter sales of $5.04 billion, up 4.6% year over year, in line with the consensus. “Second quarter performance reflects our ...

Becton, Dickinson and Company BDX is benefiting from its focused transformation into a pure-play MedTech company, supported by strong execution of its BD 2025 strategy. The company’s continued ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Becton Dickinson reported a better-than-expected third-quarter profit on Thursday, helped by strong demand for its ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Shares of Becton Dickinson & Co. BDX slid 2.07% to $150.65 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to ...